Evolutionary immuno-genetics of endoplasmic reticulum aminopeptidase II (ERAP2)

Genes Immun. 2023 Dec;24(6):295-302. doi: 10.1038/s41435-023-00225-8. Epub 2023 Nov 4.

Abstract

Endoplasmic reticulum aminopeptidase 2 (ERAP2) is a proteolytic enzyme involved in adaptive immunity. The ERAP2 gene is highly polymorphic and encodes haplotypes that confer resistance against lethal infectious diseases, but also increase the risk for autoimmune disorders. Identifying how ERAP2 influences susceptibility to these traits requires an understanding of the selective pressures that shaped and maintained allelic variation throughout human evolution. Our review discusses the genetic regulation of haplotypes and diversity in naturally occurring ERAP2 allotypes in the global population. We outline how these ERAP2 haplotypes evolved during human history and highlight the presence of Neanderthal DNA sequences in ERAP2 of modern humans. Recent evidence suggests that human adaptation during the last ~10,000 years and historic pandemics left a significant mark on the ERAP2 gene that determines susceptibility to infectious and inflammatory diseases today.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity* / genetics
  • Aminopeptidases* / genetics
  • Aminopeptidases* / immunology
  • Autoimmune Diseases / genetics
  • Autoimmune Diseases / immunology
  • Endoplasmic Reticulum* / enzymology
  • Evolution, Molecular*
  • Haplotypes
  • Humans
  • Minor Histocompatibility Antigens / genetics

Substances

  • Aminopeptidases
  • ERAP2 protein, human
  • Minor Histocompatibility Antigens